These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 8872604
1. High-affinity nuclear receptor binding of 20-epi analogues of 1,25-dihydroxyvitamin D3 correlates well with gene activation. Nayeri S, Mathiasen IS, Binderup L, Carlberg C. J Cell Biochem; 1996 Sep 01; 62(3):325-33. PubMed ID: 8872604 [Abstract] [Full Text] [Related]
2. The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors. Carlberg C, Mathiasen IS, Saurat JH, Binderup L. J Steroid Biochem Mol Biol; 1994 Nov 01; 51(3-4):137-42. PubMed ID: 7981122 [Abstract] [Full Text] [Related]
3. The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. Nayeri S, Danielsson C, Kahlen JP, Schräder M, Mathiasen IS, Binderup L, Carlberg C. Oncogene; 1995 Nov 02; 11(9):1853-8. PubMed ID: 7478614 [Abstract] [Full Text] [Related]
4. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity. Quack M, Clarin A, Binderup E, Björkling F, Hansen CM, Carlberg C. J Cell Biochem; 1998 Dec 01; 71(3):340-50. PubMed ID: 9831071 [Abstract] [Full Text] [Related]
5. Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation. Schräder M, Nayeri S, Kahlen JP, Müller KM, Carlberg C. Mol Cell Biol; 1995 Mar 01; 15(3):1154-61. PubMed ID: 7862109 [Abstract] [Full Text] [Related]
6. The potent anti-proliferative effect of 20-epi analogues of 1,25 dihydroxyvitamin D3 in human breast-cancer MCF-7 cells is related to promoter selectivity. Mørk Hansen C, Danielsson C, Carlberg C. Int J Cancer; 1996 Sep 04; 67(5):739-42. PubMed ID: 8782667 [Abstract] [Full Text] [Related]
8. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs. Quack M, Carlberg C. Mol Pharmacol; 1999 Jun 04; 55(6):1077-87. PubMed ID: 10347251 [Abstract] [Full Text] [Related]
10. Functional characterization of a 1,25-dihydroxyvitamin D3 receptor binding site found in the rat atrial natriuretic factor promoter. Kahlen JP, Carlberg C. Biochem Biophys Res Commun; 1996 Jan 26; 218(3):882-6. PubMed ID: 8579609 [Abstract] [Full Text] [Related]
11. Gene regulatory potential of 1alpha,25-dihydroxyvitamin D(3) analogues with two side chains. Bury Y, Herdick M, Uskokovic MR, Carlberg C. J Cell Biochem Suppl; 2001 Jan 26; Suppl 36():179-90. PubMed ID: 11455583 [Abstract] [Full Text] [Related]
13. Distinct conformational changes induced by 20-epi analogues of 1 alpha,25-dihydroxyvitamin D3 are associated with enhanced activation of the vitamin D receptor. Peleg S, Sastry M, Collins ED, Bishop JE, Norman AW. J Biol Chem; 1995 May 05; 270(18):10551-8. PubMed ID: 7737990 [Abstract] [Full Text] [Related]
15. Allosteric interaction of the 1alpha,25-dihydroxyvitamin D3 receptor and the retinoid X receptor on DNA. Kahlen JP, Carlberg C. Nucleic Acids Res; 1997 Nov 01; 25(21):4307-13. PubMed ID: 9336462 [Abstract] [Full Text] [Related]
19. Retinoid X receptors in the kidney: their protein expression and functional significance. Sugawara A, Sanno N, Takahashi N, Osamura RY, Abe K. Endocrinology; 1997 Aug 01; 138(8):3175-80. PubMed ID: 9231765 [Abstract] [Full Text] [Related]